Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors
- 1 June 2002
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 54 (3) , 143-147
- https://doi.org/10.1016/s0166-3542(01)00219-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and ZanamivirAntimicrobial Agents and Chemotherapy, 2001
- Evaluation of a Rapid Optical Immunoassay for Influenza Viruses (FLU OIA Test) in Comparison with Cell Culture and Reverse Transcription-PCRJournal of Clinical Microbiology, 2001
- Prevention and Treatment of InfluenzaNew England Journal of Medicine, 2000
- Inhaled Zanamivir for the Prevention of Influenza in FamiliesNew England Journal of Medicine, 2000
- Resistance of influenza viruses to neuraminidase inhibitors — a reviewAntiviral Research, 2000
- Development of a Sensitive Chemiluminescent Neuraminidase Assay for the Determination of Influenza Virus Susceptibility to ZanamivirAnalytical Biochemistry, 2000
- Rapid Antiviral Effect of Inhaled Zanamivir in the Treatment of Naturally Occurring Influenza in Otherwise Healthy AdultsThe Journal of Infectious Diseases, 2000
- Influenza virus neuraminidase inhibitorsThe Lancet, 2000
- Zanamivir Susceptibility Monitoring and Characterization of Influenza Virus Clinical Isolates Obtained during Phase II Clinical Efficacy StudiesAntimicrobial Agents and Chemotherapy, 2000
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997